ATE256670T1 - Isoxazolcarboxamid-derivate als antagonisten des alpha1-adrenergischen rezeptors - Google Patents
Isoxazolcarboxamid-derivate als antagonisten des alpha1-adrenergischen rezeptorsInfo
- Publication number
- ATE256670T1 ATE256670T1 AT00992436T AT00992436T ATE256670T1 AT E256670 T1 ATE256670 T1 AT E256670T1 AT 00992436 T AT00992436 T AT 00992436T AT 00992436 T AT00992436 T AT 00992436T AT E256670 T1 ATE256670 T1 AT E256670T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- adrenergic receptor
- carboxamide derivatives
- isoxazole carboxamide
- alpha1 adrenergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999MI002173A IT1314191B1 (it) | 1999-10-18 | 1999-10-18 | Derivati isossazolcarbossamidici |
PCT/EP2000/010144 WO2001029015A2 (en) | 1999-10-18 | 2000-10-16 | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE256670T1 true ATE256670T1 (de) | 2004-01-15 |
Family
ID=11383797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00992436T ATE256670T1 (de) | 1999-10-18 | 2000-10-16 | Isoxazolcarboxamid-derivate als antagonisten des alpha1-adrenergischen rezeptors |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1226131B1 (de) |
JP (1) | JP2003512362A (de) |
KR (1) | KR20020038944A (de) |
CN (1) | CN1139579C (de) |
AR (1) | AR029400A1 (de) |
AT (1) | ATE256670T1 (de) |
AU (1) | AU757614B2 (de) |
BR (1) | BR0014851A (de) |
CA (1) | CA2385472A1 (de) |
DE (1) | DE60007347T2 (de) |
DK (1) | DK1226131T3 (de) |
ES (1) | ES2210033T3 (de) |
HK (1) | HK1044940A1 (de) |
HU (1) | HUP0203184A3 (de) |
IL (1) | IL148837A0 (de) |
IT (1) | IT1314191B1 (de) |
MX (1) | MXPA02003432A (de) |
MY (1) | MY120400A (de) |
NO (1) | NO20021803L (de) |
NZ (1) | NZ517884A (de) |
PL (1) | PL356990A1 (de) |
PT (1) | PT1226131E (de) |
RU (1) | RU2002113096A (de) |
WO (1) | WO2001029015A2 (de) |
ZA (1) | ZA200203942B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0617306A2 (pt) | 2005-10-11 | 2011-07-19 | Hoffmann La Roche | derivados de isoxazol |
CN101304994B (zh) | 2005-11-09 | 2011-06-29 | 弗·哈夫曼-拉罗切有限公司 | 3-芳基-异噁唑-4-羰基-苯并呋喃衍生物 |
AU2006328602B2 (en) | 2005-12-23 | 2012-05-31 | F. Hoffmann-La Roche Ag | Aryl-isoxazolo-4-yl-oxadiazole derivatives |
RU2425045C2 (ru) | 2005-12-27 | 2011-07-27 | Ф. Хоффманн-Ля Рош Аг | Производные арил-изоксазол-4-ил-имидазола |
CN101370807B (zh) | 2006-01-17 | 2011-08-31 | 弗·哈夫曼-拉罗切有限公司 | 可用于经由gaba受体治疗阿尔茨海默病的芳基-异唑-4-基-咪唑并[1,2-a]吡啶 |
MX2008014796A (es) | 2006-05-31 | 2008-12-02 | Hoffmann La Roche | Derivados de aril-4-etinil-isoxazol. |
MX2009014001A (es) | 2007-06-22 | 2010-01-28 | Hoffmann La Roche | Derivados de isoxazol-imidazol. |
US7902201B2 (en) | 2007-12-04 | 2011-03-08 | Hoffmann-La Roche Inc. | Isoxazolo-pyrazine derivatives |
US7943619B2 (en) | 2007-12-04 | 2011-05-17 | Hoffmann-La Roche Inc. | Isoxazolo-pyridazine derivatives |
JP5301556B2 (ja) | 2007-12-04 | 2013-09-25 | エフ.ホフマン−ラ ロシュ アーゲー | イソオキサゾロ−ピラジン誘導体 |
WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
TW201033201A (en) | 2009-02-19 | 2010-09-16 | Hoffmann La Roche | Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
US8389550B2 (en) | 2009-02-25 | 2013-03-05 | Hoffmann-La Roche Inc. | Isoxazoles / O-pyridines with ethyl and ethenyl linker |
US8222246B2 (en) | 2009-04-02 | 2012-07-17 | Hoffmann-La Roche Inc. | Substituted isoxazoles |
US8227461B2 (en) | 2009-04-30 | 2012-07-24 | Hoffmann-La Roche Inc. | Isoxazoles |
MX2011011477A (es) | 2009-05-05 | 2011-11-18 | Hoffmann La Roche | Derivados de isoxazol-piridazina. |
SG175869A1 (en) | 2009-05-05 | 2011-12-29 | Hoffmann La Roche | Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders |
MX2011011489A (es) | 2009-05-05 | 2011-11-18 | Hoffmann La Roche | Derivados de isoxazol-piridina. |
MX2011011273A (es) | 2009-05-05 | 2011-11-04 | Hoffmann La Roche | Derivados de isoxazol-pirazol. |
SG175318A1 (en) | 2009-05-07 | 2011-11-28 | Hoffmann La Roche | Isoxazole-pyridine derivatives as gaba modulators |
US8785435B2 (en) | 2011-10-20 | 2014-07-22 | Hoffmann-La Roche Inc. | Solid forms |
CN113121540B (zh) * | 2020-01-15 | 2024-01-26 | 鲁南制药集团股份有限公司 | 一种西格列汀游离碱的合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
-
1999
- 1999-10-18 IT IT1999MI002173A patent/IT1314191B1/it active
-
2000
- 2000-10-10 MY MYPI20004718A patent/MY120400A/en unknown
- 2000-10-16 DK DK00992436T patent/DK1226131T3/da active
- 2000-10-16 PL PL00356990A patent/PL356990A1/xx not_active Application Discontinuation
- 2000-10-16 BR BR0014851-2A patent/BR0014851A/pt not_active IP Right Cessation
- 2000-10-16 PT PT00992436T patent/PT1226131E/pt unknown
- 2000-10-16 AU AU28347/01A patent/AU757614B2/en not_active Ceased
- 2000-10-16 CN CNB008143226A patent/CN1139579C/zh not_active Expired - Fee Related
- 2000-10-16 EP EP00992436A patent/EP1226131B1/de not_active Expired - Lifetime
- 2000-10-16 JP JP2001531815A patent/JP2003512362A/ja active Pending
- 2000-10-16 DE DE60007347T patent/DE60007347T2/de not_active Expired - Fee Related
- 2000-10-16 AT AT00992436T patent/ATE256670T1/de not_active IP Right Cessation
- 2000-10-16 WO PCT/EP2000/010144 patent/WO2001029015A2/en active IP Right Grant
- 2000-10-16 CA CA002385472A patent/CA2385472A1/en not_active Abandoned
- 2000-10-16 ES ES00992436T patent/ES2210033T3/es not_active Expired - Lifetime
- 2000-10-16 NZ NZ517884A patent/NZ517884A/en unknown
- 2000-10-16 MX MXPA02003432A patent/MXPA02003432A/es not_active Application Discontinuation
- 2000-10-16 IL IL14883700A patent/IL148837A0/xx unknown
- 2000-10-16 RU RU2002113096/04A patent/RU2002113096A/ru not_active Application Discontinuation
- 2000-10-16 KR KR1020027004663A patent/KR20020038944A/ko not_active Application Discontinuation
- 2000-10-16 HU HU0203184A patent/HUP0203184A3/hu unknown
- 2000-10-18 AR ARP000105475A patent/AR029400A1/es not_active Application Discontinuation
-
2002
- 2002-04-17 NO NO20021803A patent/NO20021803L/no not_active Application Discontinuation
- 2002-05-17 ZA ZA200203942A patent/ZA200203942B/en unknown
- 2002-08-13 HK HK02105918.6A patent/HK1044940A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0014851A (pt) | 2002-06-11 |
WO2001029015A2 (en) | 2001-04-26 |
NO20021803L (no) | 2002-06-17 |
CN1139579C (zh) | 2004-02-25 |
CN1379767A (zh) | 2002-11-13 |
HUP0203184A3 (en) | 2004-12-28 |
PL356990A1 (en) | 2004-07-12 |
EP1226131B1 (de) | 2003-12-17 |
ZA200203942B (en) | 2003-01-02 |
DK1226131T3 (da) | 2004-04-19 |
EP1226131A2 (de) | 2002-07-31 |
AU2834701A (en) | 2001-04-30 |
HUP0203184A2 (hu) | 2003-01-28 |
MY120400A (en) | 2005-10-31 |
IT1314191B1 (it) | 2002-12-06 |
DE60007347T2 (de) | 2004-09-02 |
NO20021803D0 (no) | 2002-04-17 |
NZ517884A (en) | 2003-08-29 |
DE60007347D1 (de) | 2004-01-29 |
KR20020038944A (ko) | 2002-05-24 |
AR029400A1 (es) | 2003-06-25 |
MXPA02003432A (es) | 2002-08-20 |
ITMI992173A0 (it) | 1999-10-18 |
HK1044940A1 (zh) | 2002-11-08 |
IL148837A0 (en) | 2002-09-12 |
PT1226131E (pt) | 2004-05-31 |
RU2002113096A (ru) | 2003-11-10 |
ES2210033T3 (es) | 2004-07-01 |
WO2001029015A3 (en) | 2001-11-01 |
AU757614B2 (en) | 2003-02-27 |
CA2385472A1 (en) | 2001-04-26 |
ITMI992173A1 (it) | 2001-04-18 |
JP2003512362A (ja) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60007347D1 (de) | Isoxazolcarboxamid-derivate als antagonisten des alpha1-adrenergischen rezeptors | |
DE60120419D1 (de) | 4-phenyl-pyridin-derivate verwendbar als neurokinin-1 rezeptor antagonisten | |
MA26929A1 (fr) | N-oxydes en tant que promedicaments antagonistes recepteurs nk1 des derives de 4-phenyl-pyridine | |
ATE288898T1 (de) | Phenylethenyl- oder phenylethinylderivate als glutamatrezeptorantagonisten | |
DE69915888D1 (de) | Sulfonamidverbindungen des hydroxydiphenylharnstoffs als il-8 rezeptorantagonisten | |
ATE235467T1 (de) | Antagonisten des vitronectin-rezeptors | |
NO20030471D0 (no) | Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor | |
NO20010151D0 (no) | N-substituerte naftalenkarboksamider som neurokininreseptorantagonister | |
ATE322496T1 (de) | 4-phenylpyridin-derivate als neurokinin-1- rezeptor-antagonisten | |
DE60028368D1 (de) | Agonisten des peroxisom aktivator-responsiven rezeptors | |
DE69939053D1 (de) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives als muskarin-rezeptor antagonisten | |
NO20004503D0 (no) | Vitronectin-reseptor-antagonister | |
NO20016053D0 (no) | IL-8 reseptor-antagonister | |
ATE286022T1 (de) | Naphthalin-carboxamide als tachykinin rezeptorantagonisten | |
NO994106L (no) | Oksazolidiner som 5-HT2A-antagonister | |
DE60017110D1 (de) | Biphenylderivate als neurokinin-1 antagonisten | |
DE50100358D1 (de) | Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten | |
NO20020644D0 (no) | Nye integrinreseptor-antagonister | |
NO20016052L (no) | IL-8-reseptor-antagonister | |
DE50008020D1 (de) | Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten | |
DK1180028T3 (da) | IL-8-receptorantagonister | |
DE60016769D1 (de) | Antagonisten des vitronectin-receptors | |
NO20015774D0 (no) | IL-8 reseptorantagonister | |
NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
ATE286882T1 (de) | Carboxy substituierte carboxamidderivative als tachykinin rezeptorantagoniste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1226131 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |